Refine by
Diabetes Type Suppliers & Manufacturers
25 companies found
based inEspoo, AUSTRALIA
Medixine was founded by medical doctor Tapio Jokinen in 2000. He was one of the first visionaries in Finland to see how digitalization was about to revolutionize healthcare. During the first 15 years of Medixine’s journey, we focused on consulting ...
Integrated care is a ‘mega-shift’ driving major change at a health-system level and is impacting the design of care delivery services globally. Research (Kings Fund) indicates that best practice integrated care programs can substantially ...
based inBagsværd, DENMARK
We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. ...
based inVancouver, BRITISH COLUMBIA (CANADA)
The Diabits app is a personalized diabetes management tool made by Bio Conscious for people with type I and type II diabetes. Using a machine learning algorithm, the Diabits app builds a personalized model of your blood sugar. Continuous glucose ...
See your future glucose values and manage your fluctuations with ease. Diabits Calculates future glucose using a Machine Learning Algorithm designed to learn your unique ...
based inMadison, WISCONSIN (USA)
Privately-owned company operating in Madison, Wisconsin (MG&E Innovation Center) and Chicago, Illinois. Team of experts in the field of stem cell research which allows RMS to make unprecedented scientific breakthroughs. Extensive experience in stem ...
We are developing autologous and allogeneic versions of ILC cellular therapeutic. In the case of autologous ILC cellular therapeutic we will convert the diabetes patients own cells into iPSC cells followed by differentiation of the patient derived ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Low plasma Lysophosphatidylcholine 18:2 also has been shown to predict impaired glucose tolerance, insulin resistance, type 2 diabetes, coronary artery disease, and memory ...
based inBoston, MASSACHUSETTS (USA)
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — ...
based inAmsterdam, NETHERLANDS
Caelus Health is an Amsterdam-based biotech company with in-depth knowledge of the microbiome, dedicated to the development and commercialization of microbiota-based products to prevent and treat cardiometabolic disorders, including Diabetes, and ...
Intestinimonas: as basis of a drug to treat Type 2 Diabetes has been tested in animal trials; a first clinical Proof of Concept study will start in ...
based inBeachwood, OHIO (USA)
We develop cell therapies - at a dramatically increased speed, at lower cost, and with less R&D risk. Trailhead Biosystems merges developmental biology and cell therapeutics with cutting-edge hardware and computerized experimental design and ...
based inLake Bluff, ILLINOIS (USA)
Realize Therapeutics is focused on providing Health Care Practitioners (HCPs) with medical nutrition solutions for their patients suffering from obesity and type 2 diabetes. Realize’s strategy is to develop microbe and endocannabinoid formulations ...
based inMontreal, QUEBEC (CANADA)
As a specialty therapeutics, clinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of diabetic kidney disease, type 1 and type 2 diabetes, ...
Inversago Pharma Inc. is focused on the development of peripherally-acting CB1 receptor (CB1) inverse agonists for the treatment of diabetic nephropathy, NASH, type 1 diabetes and Prader-Willi ...
based inNew York, NEW YORK (USA)
Oramed Pharmaceuticals (NASDAQ: ORMP) has developed an innovative technology to transform injectable treatments into oral therapies. Oramed’s flagship product, an oral insulin capsule, has the potential to better the lives of millions of diabetics ...
Diabetes is a chronic condition characterized by hyperglycemia, or elevated blood glucose levels. If left untreated, diabetes may lead to complications such as cardiovascular disease, chronic renal failure, retinopathy and ...
based inMalvern, PENNSYLVANIA (USA)
LifeScan is a global leader in blood glucose monitoring innovation and digital health technology and has a vision to create a world without limits for people with diabetes and related conditions. More than 20 million people and their caregivers ...
based inBoston, MASSACHUSETTS (USA)
Since GI Dynamics’ founding in 2003, our mission has been to alleviate the symptoms of type 2 diabetes and obesity for patients fighting these global epidemics worldwide. Our revolutionary EndoBarrier is a testament to the GI Dynamics mission. The ...
based inBlankenfelde-Mahlow, GERMANY
Medipan GmbH was founded in 1992 and is an independent, family company. The company started with the marketing of radioimmunoassays for the characterization of thyroid function, disease and tumor markers, with its partners from nuclear medicine ...
Radio ligand assay for the quantitative determination of autoantibodies to Insulin (IAA) in human ...
based inNew York, NEW YORK (USA)
Altucell, Inc. is a cellular engineering and biotech company backed by sound research and science focused on fulfilling a large 'unmet need' in cell, molecular and regenerative therapy for treatment of Diabetes and other autoimmune and ...
Microcapsules constitute immunoisolatory physical barriers that prevent immune rejection of the enveloped cells upon graft, while offering a special 3D Cell matrix like microenvironment (which greatly favors retention of cell viability and ...
based inSanta Ana, CALIFORNIA (USA)
Aqua Medical has developed a disruptive, vapor-based, endoscopic, ablation technology designed to treat gastrointestinal disease and prevent GI cancers. Aqua Medical’s unique ablation technology consists of high-temperature water vapor created by a ...
based inToronto, ONTARIO (CANADA)
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes. This pre-clinical technology is directed at regulating a hormone in the pancreas called somatostatin which in Type ...
based inMiami Lakes, FLORIDA (USA)
Biorep is ISO 13485 Certified and FDA Registered. As a full-service development firm, Biorep has an exclusive focus on medical products and over 20 years of experience developing medical devices. Biorep enables advancements in medical technologies ...
based inLondon, UNITED KINGDOM
Multiomic Health Limited is a next-generation precision medicine business, applying computational systems biology to develop and commercialize data assets for metabolic syndrome. Multiomic is a next-generation precision medicine business, applying ...
based inTualatin, OREGON (USA)
Genteel is the world’s only lancing device that uses vacuum and depth control to draw blood from anywhere on the body. This innovative, pain-free technology allows users with diabetes to check blood sugar anywhere on the body, giving sore fingertips ...
The Genteel Lancing Device allows those with diabetes to check their blood sugar without pain, using vacuum and depth control. Each Genteel comes with 6 contact tips, 2 nozzles, and a travel and organizer pouch. Compatible with most square shaft ...